Literature DB >> 23302788

Multi-functional analysis of Klebsiella pneumoniae fimbrial types in adherence and biofilm formation.

María D Alcántar-Curiel1, Dana Blackburn, Zeus Saldaña, Catalina Gayosso-Vázquez, Nicole M Iovine, Miguel A De la Cruz, Jorge A Girón.   

Abstract

Klebsiella pneumoniae is an opportunistic pathogen frequently associated with nosocomially acquired infections. Host cell adherence and biofilm formation of K. pneumoniae isolates is mediated by type 1 (T1P) and type 3 (MR/K) pili whose major fimbrial subunits are encoded by the fimA and mrkA genes, respectively. The E. coli common pilus (ECP) is an adhesive structure produced by all E. coli pathogroups and a homolog of the ecpABCDE operon is present in the K. pneumoniae genome. In this study, we aimed to determine the prevalence of these three fimbrial genes among a collection of 69 clinical and environmental K. pneumoniae strains and to establish a correlation with fimbrial production during cell adherence and biofilm formation. The PCR-based survey demonstrated that 96% of the K. pneumoniae strains contained ecpA and 94% of these strains produced ECP during adhesion to cultured epithelial cells. Eighty percent of the strains forming biofilms on glass produced ECP, suggesting that ECP is required, at least in vitro, for expression of these phenotypes. The fim operon was found in 100% of the strains and T1P was detected in 96% of these strains. While all the strains examined contained mrkA, only 57% of them produced MR/K fimbriae, alone or together with ECP. In summary, this study highlights the ability of K. pneumoniae strains to produce ECP, which may represent a new important adhesive structure of this organism. Further, it defines the multi-fimbrial nature of the interaction of this nosocomial pathogen with host epithelial cells and inert surfaces.

Entities:  

Keywords:  E. coli common pilus; K. oxytoca; Klebsiella pneumoniae; adherence; biofilms

Mesh:

Substances:

Year:  2013        PMID: 23302788      PMCID: PMC3654611          DOI: 10.4161/viru.22974

Source DB:  PubMed          Journal:  Virulence        ISSN: 2150-5594            Impact factor:   5.882


  38 in total

1.  Capsular polysaccharide is a major complement resistance factor in lipopolysaccharide O side chain-deficient Klebsiella pneumoniae clinical isolates.

Authors:  D Alvarez; S Merino; J M Tomás; V J Benedí; S Albertí
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

2.  Adherence of Escherichia coli to human mucosal cells mediated by mannose receptors.

Authors:  I Ofek; D Mirelman; N Sharon
Journal:  Nature       Date:  1977-02-17       Impact factor: 49.962

3.  Histologic fixatives suitable for diagnostic light and electron microscopy.

Authors:  E M McDowell; B F Trump
Journal:  Arch Pathol Lab Med       Date:  1976-08       Impact factor: 5.534

4.  Type 3 fimbrial shaft (MrkA) of Klebsiella pneumoniae, but not the fimbrial adhesin (MrkD), facilitates biofilm formation.

Authors:  J Langstraat; M Bohse; S Clegg
Journal:  Infect Immun       Date:  2001-09       Impact factor: 3.441

5.  A comparative study of the type-3 fimbriae of Klebsiella species.

Authors:  D C Old; A Tavendale; B W Senior
Journal:  J Med Microbiol       Date:  1985-10       Impact factor: 2.472

6.  Population shift in mannose-specific fimbriated phase of Klebsiella pneumoniae during experimental urinary tract infection in mice.

Authors:  M C Maayan; I Ofek; O Medalia; M Aronson
Journal:  Infect Immun       Date:  1985-09       Impact factor: 3.441

7.  Distinctive patterns of adherence of enteropathogenic Escherichia coli to HeLa cells.

Authors:  I C Scaletsky; M L Silva; L R Trabulsi
Journal:  Infect Immun       Date:  1984-08       Impact factor: 3.441

8.  Aromatic alpha-glycosides of mannose are powerful inhibitors of the adherence of type 1 fimbriated Escherichia coli to yeast and intestinal epithelial cells.

Authors:  N Firon; S Ashkenazi; D Mirelman; I Ofek; N Sharon
Journal:  Infect Immun       Date:  1987-02       Impact factor: 3.441

9.  Klebsiella pneumoniae: selected virulence factors that contribute to pathogenicity.

Authors:  A K Highsmith; W R Jarvis
Journal:  Infect Control       Date:  1985-02

10.  Transcriptional regulation of the ecp operon by EcpR, IHF, and H-NS in attaching and effacing Escherichia coli.

Authors:  Verónica I Martínez-Santos; Abraham Medrano-López; Zeus Saldaña; Jorge A Girón; José L Puente
Journal:  J Bacteriol       Date:  2012-07-13       Impact factor: 3.490

View more
  37 in total

1.  Nosocomial, Multidrug-Resistant Klebsiella pneumoniae Strains Isolated from Mexico City Produce Robust Biofilms on Abiotic Surfaces but Not on Human Lung Cells.

Authors:  Martha Lorena Ostria-Hernandez; Karla Cecilia Juárez-de la Rosa; Patricia Arzate-Barbosa; Antonino Lara-Hernández; Fuminori Sakai; J Antonio Ibarra; Graciela Castro-Escarpulli; Jorge E Vidal
Journal:  Microb Drug Resist       Date:  2017-09-15       Impact factor: 3.431

Review 2.  Options and Limitations in Clinical Investigation of Bacterial Biofilms.

Authors:  Maria Magana; Christina Sereti; Anastasios Ioannidis; Courtney A Mitchell; Anthony R Ball; Emmanouil Magiorkinis; Stylianos Chatzipanagiotou; Michael R Hamblin; Maria Hadjifrangiskou; George P Tegos
Journal:  Clin Microbiol Rev       Date:  2018-04-04       Impact factor: 26.132

3.  Escherichia coli common pilus (ECP) targets arabinosyl residues in plant cell walls to mediate adhesion to fresh produce plants.

Authors:  Yannick Rossez; Ashleigh Holmes; Henriette Lodberg-Pedersen; Louise Birse; Jacqueline Marshall; William G T Willats; Ian K Toth; Nicola J Holden
Journal:  J Biol Chem       Date:  2014-10-15       Impact factor: 5.157

Review 4.  Targeting the Holy Triangle of Quorum Sensing, Biofilm Formation, and Antibiotic Resistance in Pathogenic Bacteria.

Authors:  Ronit Vogt Sionov; Doron Steinberg
Journal:  Microorganisms       Date:  2022-06-16

5.  The Klebsiella pneumoniae YfgL (BamB) lipoprotein contributes to outer membrane protein biogenesis, type-1 fimbriae expression, anti-phagocytosis, and in vivo virulence.

Authors:  Pei-Fang Hsieh; Chun-Ru Hsu; Chun-Tang Chen; Tzu-Lung Lin; Jin-Town Wang
Journal:  Virulence       Date:  2016-03-30       Impact factor: 5.882

6.  Multidrug Resistance Related to Biofilm Formation in Acinetobacter baumannii and Klebsiella pneumoniae Clinical Strains from Different Pulsotypes.

Authors:  Paola Amaral de Campos; Sabrina Royer; Deivid William da Fonseca Batistão; Bruna Fuga Araújo; Lícia Ludendorff Queiroz; Cristiane Silveira de Brito; Paulo P Gontijo-Filho; Rosineide Marques Ribas
Journal:  Curr Microbiol       Date:  2016-02-04       Impact factor: 2.188

7.  Molecular characterization of KPC-2-producing Klebsiella pneumoniae ST258 isolated from bovine mastitis.

Authors:  Jesús Silva-Sanchez; Humberto Barrios-Camacho; Emmanuel Hernández-Rodriguez; Josefina Duran-Bedolla; Alejandro Sanchez-Perez; Luary C Martínez-Chavarría; Juan Xicohtencatl-Cortes; Rigoberto Hernández-Castro; Ulises Garza-Ramos
Journal:  Braz J Microbiol       Date:  2021-02-13       Impact factor: 2.476

8.  Successful treatment of infective endocarditis due to pandrug-resistant Klebsiella pneumoniae with ceftazidime-avibactam and aztreonam.

Authors:  Majed F Alghoribi; Moayad Alqurashi; Liliane Okdah; Bassam Alalwan; Yahya S AlHebaishi; Abdulmajeed Almalki; Maha A Alzayer; Abdulrahman A Alswaji; Michel Doumith; Mazin Barry
Journal:  Sci Rep       Date:  2021-05-06       Impact factor: 4.379

9.  Diversity in the swimming motility and flagellar regulon structure of uropathogenic Morganella morganii strains.

Authors:  Leyla Minnullina; Zarina Kostennikova; Vladimir Evtugin; Yaw Akosah; Margarita Sharipova; Ayslu Mardanova
Journal:  Int Microbiol       Date:  2021-08-07       Impact factor: 2.479

10.  Association between Presence of RmpA, MrkA and MrkD Genes and Antibiotic Resistance in Clinical Klebsiella pneumoniae Isolates from Hospitals in Tehran, Iran.

Authors:  Ronak Bakhtiari; Ali Javadi; Malihe Aminzadeh; Ebrahim Molaee-Aghaee; Zahra Shaffaghat
Journal:  Iran J Public Health       Date:  2021-05       Impact factor: 1.429

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.